We developed a molecular-grafting procedure to the synthesis of ultrathin 
Introduction
Targeted drug delivery triggered by various external stimulus such pH, [1] [2] [3] [4] [5] [6] [7] [8] DNA, 9-12 enzyme [13] [14] and photo, [15] [16] [17] have been attracting considerable interests due to their promising potential for many applications. Incorporation of magnetic matter into carriers that can be manipulated by external magnetic fields, in particular, have demonstrated the advantages for multi-functional use in the delivery/recovery, enzyme immobilization, 14 magnetic resonance imaging (MRI), and localized therapy such as hyperthermia. The advantage of ultrasound generated from magnetic fields is that the magnetic fields do not suffer the same attenuation as ultrasound through bones or soft tissue, and nanoparticles can be successfully delivered to various places in the human body. 18 Among the many examples reported so far, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] nanoparticles as magnetically-manipulated bars and blocking caps to control the release of fluorescein molecules. 21 Li et al. researched the hollow mesoporous silica nanoparticles with tunable structures for controlled drug delivery. 22 Zhu et al. reported the rattle-type Fe 3 O 4 / silica hollow mesoporous spheres for the loading and release of doxorubicin hydrochloride (DOX). 23 Kong et al. reported Fe 3 O 4 /silica nanoparticles for the anticancer drug delivery and the controlled on-off switchable release by remote electromagnetic field. 29 In this work, we report a protocol to synthesize ultrathin Fe 3 O 4 decorated Fe 3 O 4 /silica core/shell nanoparticles (hereafter denoted as Fe 3 O 4 /silica/u-Fe 3 O 4 ), and their use to enhanced the efficacy for the electromagnetically controllable release of anticancer drug, doxorubicin (DOX), as shown in Figure 1 . Doxorubicin is one of the most widely used anticancer drugs due to its promising potential against solid tumors. The therapy, however, is limited by dose-dependent toxic side effects which can potentially lead to heart failure due to cardiotoxicity. To overcome this problem, targeted drug delivery can provide therapeutically effective drug release directly at the tumor site to improve the treatment of cancers. The coupled doxorubicin molecules are immobilized with the amides to strongly inhibit the diffusion from the surface of nanoparticles, but they can be released at mild acid condition ascribed to the pH-clickable amide linkers. 5 When stimulated by an external electromagnetic field, the release of doxorubicin molecules exhibit an enhanced response ascribed to the co-operative hyperthermia effect of two kinds of superparamagnetic Fe 3 O 4 core and decorated u-Fe 3 O 4 nanoparticles, providing the possibility of dual-modal controllability of drug release dependent on pH and the external electromagnetic field. /silica) nanoparticles were dissolved in 20 mL DMSO, followed by sonicating for 30 min. Excess 1,2-cis-cyclohexanedicarboxylic anhydride was subsequently added and magnetically stirred for 2 h. The nanoparticles were separated by centrifuged at 9000 rpm, and mildly washed by DMSO for three times.
The grafted nanoparticles and doxorubicin hydrochloride salt (1 mg) was dissolved in 20 mL DMSO solution with 100 μL triethylamine, and magnetically stirred for 6 h at room temperature. In order to remove the free doxorubicin molecules, the doxorubicin-coupled nanoparticles were separated by centrifuged and mildly washed by pH7.4 phosphoric acidic buffer solution for three times. The release of doxorubicin from coupled Fe 3 O 4 /silica/u-Fe 3 O 4 nanoparticles was carried out at 37 o C and at pH 7.4 and 5.0 phosphoric acidic buffer solutions, respectively. The separated supernatant solution was monitored by UVVis spectra. Under the alternative electromagnetic field of the frequency of 400 kHz, the nanoparticles generate the hyperthermia effect to induce the temperature increase, and produce the DOX release. The temperature was measured by infrared thermometer (Fisher Scientific), and the postreleased solution at each measured point was immediately centrifuged at 10 o C avoiding the furthermore release.
Characterization methods
The size and morphology of nanoparticles were analyzed using a Hitachi S-4700 transmission electron microscopy (TEM) operated at a voltage of 30 kV. Microstructure and composition of the samples were characterized by using a JEOL 2010F (200 kV) high resolution TEM (HRTEM). UV-Vis spectra were collected on a Perkin Elmer Lamda 950 spectrometer. Magnetic measurements of major hysteresis loops (MHL) at different temperatures as well as zero-field cooled (ZFC) magnetization processes were performed with a Quantum Design PPMS model 6000 magnetometer.
Cell viability measurements
DOX release and the cytotoxicity of the Fe 3 O 4 /silica(porous) core/ shell nanoparticles functionalised with DOX were evaluated using adenocarcinomic human alveolar basal epithelial cells (A549, American Type Culture Collection (ATCC), USA). The medium used was Ham's F-12 (ATCC, USA) supplemented with penicillin (100 IU/mL), streptomycin (100 μg/mL) and 10% fetal bovine serum (FBS). The cells were cultured at a density of 1×10 5 cells per 1 mL of medium in 24-well culture plates at 37°C in a 5% CO 2 atmosphere. After 20 h of culture, the medium in the wells was replaced with fresh medium containing Fe 3 O 4 /silica(porous) core/shell nanoparticles (1, 5, 10 and 50 μg/mL), 
Results and discussion
The experimental details of the synthesis of two kinds of Fe 3 O 4 nanoparticles have been reported previously. 5 The Fe 3 O 4 /silica core/ shell nanoparticles with terminus amine groups and nanoporous structures were synthesized by a water-in-oil microemulsion. 0.5 ml of 1 mg/mL Fe 3 O 4 nanoparticles in cyclohexane was rapidly injected into a mixture of 1.77 g of Triton X-100, 1.6 ml of anhydrous 1-hexanol and 7 ml of cyclohexane under a strong vortex for 1 h., following the addition of 0.5 mL of ammonia solution (6 % ammonia solution) for 1 h. Subsequently, 10 μl TEOS and 10 μl AEAP3 were added in sequence to allow each step reaction for 24 h. The resultant product was centrifuged at 9000 rpm and washed with anhydrous ethanol three times, and dispersed in de-ionized water.
In the synthesis of Fe 3 O 4 /silica/u-Fe 3 O 4 nanoparticles, the u-Fe 3 O 4 nanoparticles with oleic acid stabilized surface were firstly functionalized by bromoacetic acid, forming the terminal bromine groups, which core. Specifically, such interaction is expected to induce an enhanced thermal field effect under an alternative electromagnetic field, forming uniform temperature gradient in the whole silica shell.
As one of the most widely used anticancer drugs, conjugating doxorubicin molecules in nanocarriers with controllable release has been attracting considerable attention due to its dose-dependent toxic side effects. 33 Herein we recently developed the chemical grafting protocol for constructing pH-dependent clickable linkers between the doxorubicin molecules and amine groups via 1,2-cyclohexanedicarboxylic anhydride. 1, 5 Such amides are stable at neutral pH, but charged to regenerate the amine groups at low pH, accompanying with the release of the doxorubicin molecules. The loading and cumulative release were quantitatively evaluated by comparing the normalized absorbance intensity of characteristic peaks of doxorubicin molecules at 450~550 nm. The release profiles of doxorubicin molecules at 37 o C at pH 7.4 and 5.0 are shown in Fig. 5(a) and (b) , respectively. At pH 7.4, the releasing process initially reached 4 % in 100 min, and then up to 600 min the whole release fractions was less than 8 % for both samples. The maximum loading of coupled doxorubicin molecules was about 4.1 and 1.2 mg for 100 mg Fe 3 O 4 /silica and Fe 3 O 4 /silica/u-Fe 3 O 4 nanoparticles, while 98 % and 84 % of them can be effectively released at pH 5.0 and 37 o C for 600 min, respectively. As an alternative, we herein further developed another route to remotely control the release of doxorubicin molecules using an external electromagnetic field. As is well known, magnetic particles can transform the energy of electromagnetic field to thermal form by magnetic hysteresis and eddy current losses, inducing the localized heating, which has been used as hyperthermia in tumor treatment. To exhibit the remote heating behavior, we measured the temperature-time relationship of 10 mg/ml DOX-nanoparticle/PBS suspensions under the electromagnetic irradiation of 400 kHz. The results showed that the temperature increases for two different samples rise up to 70 o C and 50 o C with 10 min, respectively, as shown in Figure 6 (a). The temperature gradient in the whole silica shell is reasonably expected to be higher than that we observed and plays critical role in accelerating the diffusion and release of loaded DOX molecules. 
Conclusions
We have demonstrated a proof-of-concept for the synthesis of pH and electromagnetic field dual-triggered drug release vehicle by decorating ultrathin Fe 3 O 4 nanoparticles on the surface of Fe 3 O 4 /silica core/shell nanoparticles. This new magnetic architecture offer a properties required for drug delivery, meanwhile, providing the possibility to enhance the magnetic manipulation, hyperthermia, and magnetic imaging functions.
